|
Search
HICCC Annual Symposium: Epigenetics and Cancer
| Date: | May 23, 2012 from 9:00 am to 6:00 pm EDT |
| Location: | Russ Berrie Pavilion, Room 1&2 1150 St. Nicholas Avenue at 168th Street |
| Contact: | For further information regarding this event, please contact Maria Batori by sending email to mb3155@columbia.edu or by calling 212-851-4764. |
Morning Session
8:50 am Welcome and Introduction
Stephen Emerson, MD, PhD
Director, Herbert Irving Comprehensive Cancer Center
Session I Chaired by Mary Beth Terry, PhD
9:00 am Stephen Baylin, MD
The Johns Hopkins University School of Medicine
“Key Sspects of the Cancer Epigenome – Biological
and Translational Implications”
9:40 am Timothy Bestor, PhD
Columbia University Medical Center
“Methylation Suicide in Mammary Carcinoma"
10:20 am Joseph Costello, PhD
University of California, San Francisco
"Genome-Epigenome Interactions During Malignant Transformation"
11:00 am Coffee Break
11:20 am Regina Santella, PhD
Columbia University Medical Center
“DNA Methylation in Cancer Risk and Diagnosis”
12:00 pm Peter Jones, PhD
University of Southern California
“Driver and Passenger Methylation Abnormalities in Cancer”
12:40 pm Lunch
Afternoon Session
2:00 pm
Rudolph Jaenisch, MD, MIT, Whitehead Institute
“Stem Cells. Pluripotency and Nuclear Reprogramming”
Session II Chaired by Adolfo Ferrando, MD, PhD
3:00 pm Scott Armstrong, MD, PhD
Harvard Medical School
“Epigenetic Mechanisms in Leukemia Stem Cell Development”
3:40 pm Laura Pasqualucci, MD
Columbia University Medical Center
“Disruption of Histone/Chromatin Modification Genes by
Genetic Lesions in Diffuse Large B Cell Lymphoma”
4:20 pm Coffee Break
4:40 pm Ari Melnick, MD
Weill Cornell Medical College
“Epigenetic basis and therapeutic targeting of lymphoid neoplasms”
5:20 pm Adolfo Ferrando, MD, PhD
Columbia University Medical Center
“Epigenetic Tumor Suppressors in the Pathogenesis of T-cell leukemia"
6:00 pm Closing Remarks
